RIPK2 as a prognostic biomarker and predictor of aggressive prostate cancer.

被引：0
|
作者：
Hammudi, Mustafa
Aldhahri, Walaa
Kalola, Akshar
McCullum, Catherine
Motoni, Caddie
Martha, Antonio
Rajendran, Rithika
Nava, Victor
Estephan, Fayez
Byrne, Morgan
Diao, Guoqing
Jain, Maneesh Rajiv
机构：
[1] George Washington Univ Hosp, Washington, DC USA
[2] Uniformed Serv Univ Hlth Sci, Sch Med, Washington, DC USA
[3] Washington DC VA Med Ctr, Washington, DC USA
[4] Washington DC VA Med Ctr, Dept Pathol, Washington, DC USA
[5] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
211
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prostate stromal transcriptome as biomarker of aggressive prostate cancer.
    Zhou, Yinglu
    Ma, Chaoran
    Fanelli, Giuseppe Nicolo
    Stefanizzi, Lavinia
    Gazeeva, Elizaveta
    Mucci, Lorelei A.
    Loda, Massimo
    Tyekucheva, Svitlana
    Penney, Kathryn L.
    CANCER RESEARCH, 2021, 81 (13)
  • [2] RIPK2: a promising target for cancer treatment
    You, Jieqiong
    Wang, Ying
    Chen, Haifeng
    Jin, Fang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor
    Hwang, Michael J.
    Bryant, Kelly G.
    Seo, Jae H.
    Liu, Qin
    Humphrey, Peter A.
    Melnick, Mary Ann C.
    Altieri, Dario C.
    Robert, Marie E.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (06): : 1180 - 1189
  • [4] Prognostic impact of clinical and pathologic criteria in neuroendocrine and aggressive variant prostate cancer.
    Karir, Beerinder S.
    Vlachostergios, Panagiotis J.
    Christos, Paul J.
    Febles, Victor R. A.
    Pinto-Chengot, Kavya
    Molina, Ana M.
    Nanus, David M.
    Beltran, Himisha
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis
    Zare, Alaa
    Petrova, Alexandra
    Agoumi, Mehdi
    Amstrong, Heather
    Bigras, Gilbert
    Tonkin, Katia
    Wine, Eytan
    Baksh, Shairaz
    CANCERS, 2018, 10 (06)
  • [6] High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
    Yuqing Shen
    Hui Lin
    Kelie Chen
    Wanzhong Ge
    Dajing Xia
    Yihua Wu
    Weiguo Lu
    Journal of Ovarian Research, 15
  • [7] High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
    Shen, Yuqing
    Lin, Hui
    Chen, Kelie
    Ge, Wanzhong
    Xia, Dajing
    Wu, Yihua
    Lu, Weiguo
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [8] Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis
    Yan, Yiwu
    Zhou, Bo
    Qian, Chen
    Vasquez, Alex
    Kamra, Mohini
    Chatterjee, Avradip
    Lee, Yeon-Joo
    Yuan, Xiaopu
    Ellis, Leigh
    Di Vizio, Dolores
    Posadas, Edwin M.
    Kyprianou, Natasha
    Knudsen, Beatrice S.
    Shah, Kavita
    Murali, Ramachandran
    Gertych, Arkadiusz
    You, Sungyong
    Freeman, Michael R.
    Yang, Wei
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [9] Aquaporins as Prognostic Biomarker in Prostate Cancer
    Kushwaha, Prem Prakash
    Verma, Shiv
    Gupta, Sanjay
    CANCERS, 2023, 15 (02)
  • [10] Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis
    Yiwu Yan
    Bo Zhou
    Chen Qian
    Alex Vasquez
    Mohini Kamra
    Avradip Chatterjee
    Yeon-Joo Lee
    Xiaopu Yuan
    Leigh Ellis
    Dolores Di Vizio
    Edwin M. Posadas
    Natasha Kyprianou
    Beatrice S. Knudsen
    Kavita Shah
    Ramachandran Murali
    Arkadiusz Gertych
    Sungyong You
    Michael R. Freeman
    Wei Yang
    Nature Communications, 13
12345